Astragalus Gummifer

Astragalus gummifer  Labill.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Fabaceae; Papilionaceae.
Habitat Highlands of Asia Minor, Iran, Greece, Syria and Russia.
English Tragacanth Gum.
Unani Katiraa, Kataad (Gum)
Action Demulcent, emollient (used for irritation of the internal mucosa, colitis, dry coughs), laxative. Mucilage used as an application to burns.
Taxonomic Cohort Genus Astragalus (5 documented species); Family Fabaceae (25 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Astragalus gummifer (taxonomically cited with authority Labill.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Fabaceae; Papilionaceae (primary family classification: Fabaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Highlands of Asia Minor, Iran, Greece, Syria and Russia.

Across classical and vernacular Indian systems of medicine, Astragalus gummifer is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Tragacanth Gum; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Katiraa, Kataad (Gum). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Astragalus gummifer are: Demulcent, emollient (used for irritation of the internal mucosa, colitis, dry coughs), laxative. Mucilage used as an application to burns. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Astragalus gummifer establish the following evidence base: The gum contains polysaccharides and proteinaceous polysaccharides. Tragacanthin is water-soluble, consisting of an arbinogalactan and tragacanthic acid. Bassorin is an insoluble methylated fraction (gel). The polysaccharides have been shown to have immunostimulating activity (stimulation of phagocytosis and an increase in plasma cell counts of T-lymphocytes. Although tragacanth increases weight of stool and decreases gastrointestinal transit time, it does not appear to affect cholesterol triglyceride or phospholipid levels as other soluble fibres do. (Natural Medicines Comprehensive Database, 2007.) Tragacanth has been shown to be active against a variety of tumours. It appears to inhibit growth of cancer cells.

image2

Botanical Reference 1: Astragalus gummifer — Botanical specimen

image3

Botanical Reference 2: Astragalus gummifer — Botanical specimen

image3

Botanical Reference 3: Astragalus gummifer — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Astragalus comprises 5 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Astragalus candolleanus (Action: Depurative, bechic, blood purifier (used in skin diseases). Root powder and…); Astragalus hamosus (Action: Nervine tonic (used in nervous and catarrhal affections), antirheumatic…); Astragalus sarcocola (Action: Gum—antirheumatic, aperient, anthelmintic, emollient); Astragalus strobiliferus (Action: Gum—an Indian substitute for tragacanth (A. gummifer gum)). Comparing Astragalus gummifer alongside its congeners in genus Astragalus highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Fabaceae encompasses 25 documented medicinal species (1.38% of the 1,814-species flora). Other representative medicinal members of Fabaceae include: Astragalus candolleanus (Rudanti), Astragalus hamosus (Tonkin bean), Astragalus sarcocola (Rudanti), Astragalus strobiliferus (Indian Gum tragacanth), Cyamopsis tetragonoloba (Kshudra Shimbi). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 25 medicinal species of family Fabaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Astragalus gummifer follow the plant-part modalities specified under its therapeutic action (Demulcent, emollient (used for irritation of the internal mucosa, colitis, dry coughs), laxative. Mucilage used as an application to burns), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Astragalus gummifer integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top